Stock Groups

Nevada to join $26 billion opioid settlement with J&J, drug distributors -Breaking

by Mike Robinson

[ad_1]

© Reuters. FILE PHOTO: The Johnson & Johnson logo is displayed on a screen on the floor of the New York Stock Exchange (NYSE) in New York, U.S., May 29, 2019. REUTERS/Brendan McDermid/File Photo

(Reuters) – Nevada has agreed to join a proposed nationwide settlement worth up to $26 billion resolving claims that three large U.S. drug distributors and the drugmaker Johnson & Johnson (NYSE:) fueled a deadly opioid epidemic, the state’s attorney general said on Tuesday.

Nevada was one of a handful of states that until now was not participating in the landmark accord that would resolve thousands of opioid lawsuits against J&J, McKesson Corp (NYSE:), AmerisourceBergen (NYSE:) Corp and Cardinal Health Inc (NYSE:).

Disclaimer: Fusion MediaWe remind you that this site does not contain accurate or real-time data. CFDs are stocks, futures, indexes or Forex. The prices of Forex and CFDs are not supplied by exchanges. They are instead provided by market makers. Because prices might not reflect the market, they may be incorrect. This means that prices cannot be considered indicative and are inappropriate for trading. Fusion Media is not responsible for trading losses that may be incurred as a consequence of the use of this data.

Fusion MediaFusion Media and anyone associated with it will not assume any responsibility for losses or damages arising from the use of this information. This includes data including charts and buy/sell signal signals. Trading the financial markets is one of most risky investment options. Please make sure you are fully aware about the costs and risks involved.

[ad_2]